Periodontal inflamed surface area as a novel numerical variable describing periodontal conditions

- ¹Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam, Korea.
- ²Division of Statistics, Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Korea.
- ³Department of Periodontology, Dankook University Jukjeon Dental Hospital, Yongin, Korea.
- ⁴Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam, Korea.
- ⁵Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- ⁶Department of Molecular Medicine and Biopharmaceutical Sciences, BK21 Plus Graduate School of Convergence Science and Technology, Medical Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- ⁷Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- ⁸Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Correspondence: Hyo-Jung Lee. Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital, 82 Gumi-ro 173-beon-gil, Bundang-gu, Seongnam 13620, Korea. Email: periolee@gmail.com , Tel: +82-31-787-7547, Fax: +82-31-787-4068

^†Shin-Young Park and Soyeon Ahn contributed equally to this study.

Received August 30, 2017; Accepted September 26, 2017.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/).

Abstract

Purpose

A novel index, the periodontal inflamed surface area (PISA), represents the sum of the periodontal pocket depth of bleeding on probing (BOP)-positive sites. In the present study, we evaluated correlations between PISA and periodontal classifications, and examined PISA as an index integrating the discrete conventional periodontal indexes.

Methods

This study was a cross-sectional subgroup analysis of data from a prospective cohort study investigating the association between chronic periodontitis and the clinical features of ankylosing spondylitis. Data from 84 patients without systemic diseases (the control group in the previous study) were analyzed in the present study.

Results

PISA values were positively correlated with conventional periodontal classifications (Spearman correlation coefficient=0.52; P<0.01) and with periodontal indexes, such as BOP and the plaque index (PI) (r=0.94; P<0.01 and r=0.60; P<0.01, respectively; Pearson correlation test). Porphyromonas gingivalis (P. gingivalis) expression and the presence of serum P. gingivalis antibodies were significant factors affecting PISA values in a simple linear regression analysis, together with periodontal classification, PI, bleeding index, and smoking, but not in the multivariate analysis. In the multivariate linear regression analysis, PISA values were positively correlated with the quantity of current smoking, PI, and severity of periodontal disease.

Conclusions

PISA integrates multiple periodontal indexes, such as probing pocket depth, BOP, and PI into a numerical variable. PISA is advantageous for quantifying periodontal inflammation and plaque accumulation.

Graphical Abstract

Keywords

Dental plaque; Inflammation; Periodontal diseases; Periodontal index; Porphyromonas gingivalis

INTRODUCTION

Chronic periodontitis is an inflammatory disease induced by pathogenic periodontal bacteria [1, 2]. Porphyromonas gingivalis (P. gingivalis) is a bacterium commonly associated with chronic periodontitis [3, 4, 5] and is responsible for stimulating inflammatory responses related to tissue destruction in some areas [6, 7]. Recently, P. gingivalis has been revisited as a “keystone pathogen” for plaque formation and growth via its synergistic interactions with other pathogens [8].

Conventionally, periodontal diseases are classified according to the clinical attachment level (CAL) [9, 10, 11]. The CAL indicates the degree of attachment loss, which is the sum of gingival recession and the probing pocket depth (PPD). Gingival recession implies past inflammation of the site, while an elevated PPD suggests current inflammation. Accordingly, the CAL is an index that represents inflammation in the past and present and is advantageous for determining the prognosis of individual teeth [12, 13].

Recently, an attempt was made to quantify the present inflammatory burden posed by periodontal diseases. The periodontal inflamed surface area (PISA) is the sum of the PPD of bleeding on probing (BOP)-positive sites for the total dentition and can be easily calculated using routine periodontal charting [14]. Gingival bleeding is a critical sign of inflammation and a useful parameter for identifying teeth with active inflammation [15, 16]. PISA values represent the degree of periodontal inflammation in a quantitative manner and can be used to distinguish subjects with actively inflammatory dentition from those with non-inflamed or healed dentition. However, the relationship between PISA and conventional periodontal indexes has not been examined in systemically healthy periodontal patients. In addition, the presence of periodontal pathogens has not been evaluated in relation to the periodontal inflammatory burden.

This study aimed to evaluate associations between PISA and periodontal disease. For this purpose, correlations between PISA and conventional periodontal indexes and classifications were examined, and the association between PISA and P. gingivalis expression was investigated.

MATERIALS AND METHODS

Study subjects

This study was a cross-sectional post-hoc analysis of data from a prospective cohort study investigating the association and impact of chronic periodontitis on the clinical features of ankylosing spondylitis (AS) [17]. In the original cohort study, 84 AS patients from the Rheumatology Clinic at Seoul National University Bundang Hospital were enrolled, and age- (within 5 years) and gender-matched healthy controls (n=84) were recruited from the same geographical area through local advertisements. The present study used data from the healthy controls without AS because the AS patients had been taking anti-inflammatory drugs affecting gingival inflammation, including sulfasalazine (n=25), anti-tumor necrosis factor alpha agents (n=25) or non-steroidal anti-inflammatory agents regularly or as needed (n=63).

Subjects were excluded if they had received periodontal therapy within the previous 6 months or had taken antimicrobial agents, immunosuppressive drugs, or corticosteroids within 3 months before enrollment. Additional exclusion criteria included a history of diabetes or clinical inflammatory bowel disease. The study was approved by the local Ethical Committees (IRB No. B-1206/156-001), and written informed consent was obtained from all participants. The study complied with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.

Clinical data collection

Age, gender, smoking and drinking history, socioeconomic status, education levels, co-morbidities, recent medication history, body mass index (BMI), dental visits within the past 12 months, and brushing habits were recorded at baseline for all subjects by a well-trained oral health researcher.

Periodontal examination and conservative periodontal treatment

A periodontal examination that included the plaque index (PI), PPD, CAL, and BOP was performed by a single dentist (Lee JT) at 6 sites per tooth, excluding the third molars, using a University of North Carolina (UNC)-15 periodontal probe (Hu Friedy, Chicago, IL, USA). The BOP was presented as the ratio of the BOP-positive surface to the total dental surface and the PI as the ratio of the plaque-positive surface to the total dental surface. All measurements were made as previously described [11, 18, 19].

In this study, chronic periodontitis was defined according the following criteria proposed by the Centers for Disease Control and Prevention working group. Severe periodontitis was defined as at least 2 sites with attachment loss ≥6 mm (not on the same tooth) and at least 1 site with a PD ≥5 mm. At least 2 sites with attachment loss ≥4 mm (not on same tooth) or at least 2 sites with a PD ≥5 mm indicated moderate periodontitis. If neither moderate nor severe periodontitis applied, mild periodontitis was recorded [11].

Analysis of gingival crevicular fluid (GCF)

The presence of P. gingivalis DNA in crevicular fluid was identified with a polymerase chain reaction (PCR)-based investigation [20]. GCF was collected from the tooth with the deepest sites using 3 sterile paper points (Diadent Group International, Burnaby, Canada). Prior to sampling, the sites were cleaned of supragingival plaque and saliva using sterile cotton pellets and were isolated with cotton rolls and air [21]. Each paper point was inserted into the gingival crevice until it met resistance and left in place for 30 seconds. The paper points with GCF were immediately placed in a sterile tube and stored at −20°C until they were analyzed. The presence of P. gingivalis was determined using rpoB-specific primers (GenBank accession No. NC_010729), as previously reported [22]. The templates were prepared by suspending the paper strip in 200 μL of sterile water, followed by boiling for 10 minutes and centrifuging for 30 minutes. The 143-bp PCR products were detected on 1.5% agarose gel. The presence of P. gingivalis was determined based on whether the PCR test result was positive.

Analysis of blood samples

Peripheral venous blood was sampled at enrollment and then centrifuged, and the serum was stored at −80°C. P. gingivalis strain FDC381 (ATCC^® BAA-1703™) was grown in brain-heart infusion broth (Difco, Detroit, MI, USA) supplemented with hemin (5 μg/mL), vitamin K (0.5 μg/mL), and cysteine (0.05%). The cultures were incubated under anaerobic conditions at 37°C for 3 days. After the removal of the media, the P. gingivalis cells were washed with phosphate-buffered saline 3 times and then treated with 3% formaldehyde. After centrifugation, the cells were washed with sodium carbonate coating buffer (pH 9.6). A 96-well microtiter plate (NUNC, Roskilde, Denmark) was coated with 1×10⁷ cells/well in 50 mM sodium carbonate coating buffer (pH 9.6) overnight at 4°C. After blocking with albumin, serum diluted to 1:200 or more was added to the plate. Anti-P. gingivalis immunoglobulin G (IgG) antibodies were detected using horseradish peroxidase conjugated to anti-human IgG antibodies (1:6,000 dilution, Millipore, Billerica, MA, USA) and 3,3′,5,5′-tetramethylbenzidine (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD, USA). The serum antibody level was defined as the inverse value of the largest serial dilution for which detectable antibodies were observed.

Statistical analysis

After the creation of the original study database, 2 authors (Park SY and Ahn S) pre-planned all the statistical analyses. Prior to the statistical analysis, a power analysis of this study was performed. At a given sample size of 84 subjects and with an odds ratio of 2, a P. gingivalis DNA detection prevalence of 0.4, and a significance level of 0.05, the power analysis for the logistic regression analysis was calculated as 81.8% (G*Power 3.1.5, Franz Faul, Universität Kiel, Germany).

One-way analysis of variance with the Bonferroni post hoc test or χ² test was performed to examine the periodontal condition according to the conventional classification. To examine the relationship between PISA and periodontal conditions, the Student's t-test, Spearman rank correlation test, or the Pearson correlation test was conducted using PISA and periodontal variables. To evaluate the associations between PISA and periodontal conditions, univariate linear regression analysis was performed to identify other significant variables affecting PISA values (P<0.1). In this analysis, the PISA and serum P. gingivalis antibody level values were log-transformed because of their skewness. BMI, smoking, classification of periodontal diseases, brushing, BOP, PI, P. gingivalis expression, and serum P. gingivalis antibody levels significantly influenced PISA values. Among these factors, BOP and current smoking were excluded as variables for the multivariate analysis due to their collinearity. For PISA and other significant variables, a final model was established for multivariate linear regression. P values <0.05 were considered to indicate statistical significance. The statistical analyses were performed using STATA/SE13 (Stata Corp., College Station, TX, USA).

RESULTS

The characteristics of the subjects included in this study are summarized in Table 1. Of a total of 84 subjects, 68 were male and 16 were female. Because of the etiology of AS, the age- and gender-matched control group that was used in the present study also had more male subjects. The mean (standard deviation) age of the subjects was 37.8 years (11.1 years). Thirty-five subjects (41%) were positive for P. gingivalis DNA. Of the 84 subjects, 28 (33%) were diagnosed with no or mild periodontitis, 40 (48%) with moderate periodontitis, and 16 (19%) with severe periodontitis. BOP (%), PI (%), the proportion of P. gingivalis DNA detection in the group, and serum P. gingivalis antibody levels increased with disease severity, and this trend was statistically significant (Figure 1).

Table 1
Characteristics of the subjects included in this study

Click for larger image
Click for full table
Download as Excel file

Figure 1
Periodontal conditions according to the severity of periodontal disease (A-D). Box-plot diagrams showing BOP (%) and PI (%) according to the severity of periodontal disease; BOP and PI increased with disease severity (P=0.04 and P=0.10, respectively; 1-way ANOVA with the Bonferroni post hoc test; A and B). A histogram showing P. gingivalis DNA detection in periodontal patients; P. gingivalis DNA detection was more frequently observed in subjects with severe periodontal disease (P<0.01; χ² test; C). A box-plot diagram showing that serum P. gingivalis antibody levels were also higher in patients with severe periodontal disease (P<0.01 and P<0.01, respectively; 1-way ANOVA with the Bonferroni post hoc test; D).

BOP: bleeding on probing, PI: plaque index, ANOVA: analysis of variance, P. gingivalis: Porphyromonas gingivalis.

Correlations between PISA and variables affecting periodontal disease

PISA values increased with increasing periodontal disease severity, and this difference was statistically significant (Spearman correlation coefficient=0.52; P<0.01; Figure 2A). In addition, the PISA values showed a positive correlation with the BOP index and the PI (r=0.94; P<0.01 and r=0.60; P<0.01, respectively; Pearson correlation test; Figure 2B and C). The subjects in the P. gingivalis (+) group had significantly higher PISA values than those in the P. gingivalis (−) group (P<0.01; Figure 2D).

Figure 2
Correlation of PISA values with periodontal conditions (A-D). A box-plot diagram showing PISA levels in periodontal patients according to the severity of the diseases; PISA values significantly increased with increasing periodontal disease severity (Spearman correlation coefficient=0.52; P<0.01; A). Scatter plots showing correlations of PISA and BOP and of PISA and PI (r=0.94; P<0.01 and r=0.60; P<0.01, respectively; Pearson correlation test; B and C). A box-plot diagram showing PISA values in subjects in P. gingivalis (+) or P. gingivalis (−) groups; the P. gingivalis (+) group showed significantly higher PISA values than the P. gingivalis (−) group (P<0.01, Student t-test; D).

PISA: periodontal inflamed surface area, BOP: bleeding on probing, PI: plaque index, P. gingivalis: Porphyromonas gingivalis.

PISA values as a multifunctional index integrating the conventional periodontal indexes

In the multivariate linear regression analysis, the quantity of current smoking, the presence of periodontal disease, and PI were significantly associated with PISA values (Table 2). P. gingivalis DNA detection and serum P. gingivalis antibody levels did not significantly influence the PISA value. In a prediction curve to estimate PISA values, it was found that PISA values increased with the PI and quantity of current smoking (Figure 3). However, PISA values did not significantly differentiate moderate periodontitis from severe periodontitis, although they showed distinct values between mild periodontitis and the other types.

Table 2
Linear regression analysis of factors affecting PISA

Click for larger image
Click for full table
Download as Excel file

Figure 3
Graphs predicting PISA values according to the multivariate linear regression analysis. PISA values increased with PI and the quantity of current smoking (A). When the severity of periodontal disease was incorporated into the analysis, the PISA value also increased with increasing PI, but there was no difference between moderate and severe disease, although PISA values showed distinct values between mild disease and moderate or severe periodontitis (B).

PISA: periodontal inflamed surface area, PI: plaque index.

DISCUSSION

In this study, we demonstrated that PISA is a representative periodontal index describing periodontal inflammation. PISA showed significant correlations with conventional periodontal classifications or indexes and significantly increased with PI and the quantity of current smoking. To our knowledge, this study is the first to investigate the factors affecting PISA in systemically healthy periodontal patients.

Unlike conventional periodontal indexes, PISA values represent an individual's periodontal condition as a continuous variable, which avoids the loss of information during statistical analysis [23]. PISA facilitated multivariate regression analysis, as a variable that integrates disease severity and conventional periodontal measurements, such as BOP and PI. Continuous variables have some merits in data processing compared with categorical variables. Furthermore, PISA values integrate periodontal conditions into a value rather than presenting them as discrete data. For example, although massive datasets have resulted from conventional periodontal charting (data from 168 PPDs, 168 CALs, 168 BOPs, 168 gingival indexes, and 168 PI values can be obtained from a person with 28 teeth if 6 sites per tooth are measured), the data are discrete and can be difficult to apply and integrate for statistical analysis. In addition, data losses occur during the data processing for statistical analysis, and accurate descriptions of the patient may be unavailable at times. Therefore, PISA is an advantageous index, as it represents a subject’s periodontal condition as a continuous variable.

In addition, PISA might bridge the gap between conventional periodontal classifications and an individual's current periodontal status. In a recent review of periodontal disease and cardiovascular diseases, some previous studies have failed to identify statistical associations between periodontal and systemic diseases [24]. However, other studies using PISA values to determine periodontal status showed a significant relationship between periodontal and systemic diseases [25, 26]. Therefore, PISA could be considered an alternative periodontal index that represents an individual's periodontal status and could be widely applied in various periodontal studies. However, the evidence supporting PISA as a comprehensive periodontal index remains insufficient, and this study may provide the scientific background for using PISA to assess chronic periodontitis.

P. gingivalis is one of the major pathogens implicated in chronic periodontitis, and 88% of the subjects with severe periodontitis were P. gingivalis (+) in this study. Recently, P. gingivalis has emerged as a target bacterium for explaining the relationship between periodontal and systemic diseases [27, 28] and has been suggested to be a pathogen responsible for the propagation of rheumatoid arthritis (RA) [29, 30]. P. gingivalis is the only known pathogen expressing peptidylarginine deiminase, which induces adaptive immune responses, including the production of anti-citrullinated peptide antibody, which is exclusive to RA [31, 32]. Our previous study showed that P. gingivalis carriage status was associated with spinal dysmobility in AS patients [17]. However, the present study failed to show a significant relationship between P. gingivalis DNA detection, PISA, and serum P. gingivalis antibody levels. Since periodontal diseases are caused by complex pathogens including P. gingivalis, the total amount of plaque was a more significant factor inducing periodontal inflammation in this study. Similarly, serum P. gingivalis antibodies did not significantly influence periodontal inflammation. The role of the specific antibody remains controversial. Some researchers have reported that the antibody exerted positive actions in treatment and was associated with a better disease prognosis [2, 33, 34]. In contrast, others have suggested that elevated antibody levels are a result of repeated bacterial infections, rather than an ability to clear the subgingival infection [35, 36]. Therefore, antibodies to P. gingivalis and the presence of P. gingivalis did not weaken or aggravate periodontal inflammation in systemically healthy periodontal patients.

Smoking is well-known factor affecting periodontal inflammation. The harmful effects of smoking were thoroughly reviewed in an article by Kinane and Chestnutt [37]. Smoking influences host-related factors through its impacts on the subgingival niche and the microflora therein, as well as the host defense system, including the inflammatory and immune systems. In addition, periodontal treatment outcomes are also influenced by smoking; smokers show less resolution of gingival inflammation, less reduction of PPD, and less gain of CAL than non-smokers. Müller et al. [38], in a longitudinal study, reported that smokers had a high risk of transitioning from non-BOP to BOP. Therefore, smoking increases the number of BOP-positive sites, corresponding to an increase in PISA. Indeed, the quantity of current smoking increased PISA in a dose-dependent manner. Therefore, current smoking is considered to be a strong confounder affecting the results of studies about periodontal inflammation and systemic diseases when PISA is used as a periodontal index.

This study has several limitations. First, this study was a sub-group analysis, and the sample size was not sufficient to control for the many confounding variables or for comparative subgroup analyses. Second, we did not perform quantitative measurements of P. gingivalis, and correlations between P. gingivalis and PISA could not be examined. Third, the effects of other representative periodontal pathogens on PISA were not evaluated. To confirm the additional effect of specific pathogens on periodontal inflammation, a quantitative analysis through standardization of the GCF sampling methods is needed in further studies.

In conclusion, PISA was closely correlated with conventional periodontal indexes and was significantly associated with plaque and smoking quantity. For the general application of PISA, further cross-sectional clinical studies in large populations and longitudinal studies of the changes in PISA values with disease progression and remission should be conducted.

Notes

Funding:This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI14C2175). The data collection was supported by a grant from the Abbott investigator-initiated research program (IMM-12-0004).

Author Contributions:

Conceptualization: Shin-Young Park, Soyeon Ahn, Hyo-Jung Lee.
Formal analysis: Shin-Young Park, Soyeon Ahn.
Investigation: Jung-Tae Lee, Joo Youn Lee.
Methodology: Yun Jong Lee, Yeong Wook Song, Hyo-Jung Lee.
Project administration: Yun Jong Lee, Yoon-Seok Chang.
Writing - original draft: Shin-Young Park, Soyeon Ahn.
Writing - review & editing: Pil-Young Yun, Hyo-Jung Lee.

Conflict of Interest:No potential conflict of interest relevant to this article was reported.

References

1. Consensus report. Periodontal diseases: pathogenesis and microbial factors. Ann Periodontol 1996;1:926–932.
  CrossRef
1. Kinane D, Bouchard P. Group E of European Workshop on Periodontology. Periodontal diseases and health: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008;35:333–337.
  PubMed
  
  CrossRef
1. Kawada M, Yoshida A, Suzuki N, Nakano Y, Saito T, Oho T, et al. Prevalence of Porphyromonas gingivalis in relation to periodontal status assessed by real-time PCR. Oral Microbiol Immunol 2004;19:289–292.
  PubMed
  
  CrossRef
1. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38:135–187.
  PubMed
  
  CrossRef
1. Slots J. Casual or causal relationship between periodontal infection and non-oral disease? J Dent Res 1998;77:1764–1765.
  PubMed
  
  CrossRef
1. Haffajee AD, Socransky SS, Lindhe J, Kent RL, Okamoto H, Yoneyama T. Clinical risk indicators for periodontal attachment loss. J Clin Periodontol 1991;18:117–125.
  PubMed
  
  CrossRef
1. Brown LF, Beck JD, Rozier RG. Incidence of attachment loss in community-dwelling older adults. J Periodontol 1994;65:316–323.
  PubMed
  
  CrossRef
1. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011;10:497–506.
  PubMed
  
  CrossRef
1. American Academy of Periodontology Task Force report on the update to the 1999 classification of periodontal diseases and conditions. J Periodontol 2015;86:835–838.
  CrossRef
1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1–6.
  PubMed
  
  CrossRef
1. Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol 2007;78:1387–1399.
  PubMed
  
  CrossRef
1. Gilbert GH, Shelton BJ, Chavers LS, Bradford EH Jr. Predicting tooth loss during a population-based study: role of attachment level in the presence of other dental conditions. J Periodontol 2002;73:1427–1436.
  PubMed
  
  CrossRef
1. McGuire MK, Nunn ME. Prognosis versus actual outcome. II. The effectiveness of clinical parameters in developing an accurate prognosis. J Periodontol 1996;67:658–665.
  PubMed
  
  CrossRef
1. Nesse W, Abbas F, van der Ploeg I, Spijkervet FK, Dijkstra PU, Vissink A. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 2008;35:668–673.
  PubMed
  
  CrossRef
1. Greenstein G, Caton J, Polson AM. Histologic characteristics associated with bleeding after probing and visual signs of inflammation. J Periodontol 1981;52:420–425.
  PubMed
  
  CrossRef
1. Lang NP, Joss A, Orsanic T, Gusberti FA, Siegrist BE. Bleeding on probing. A predictor for the progression of periodontal disease? J Clin Periodontol 1986;13:590–596.
  PubMed
  
  CrossRef
1. Kang EH, Lee JT, Lee HJ, Lee JY, Chang SH, Cho HJ, et al. Chronic periodontitis is associated with spinal dysmobility in patients with ankylosing spondylitis. J Periodontol 2015;86:1303–1313.
  PubMed
  
  CrossRef
1. O’Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol 1972;43:38.
  CrossRef
1. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229–235.
  PubMed
1. Atieh MA. Accuracy of real-time polymerase chain reaction versus anaerobic culture in detection of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis: a meta-analysis. J Periodontol 2008;79:1620–1629.
  PubMed
  
  CrossRef
1. Golub LM, Kleinberg I. Gingival crevicular fluid: a new diagnostic aid in managing the periodontal patient. Oral Sci Rev 1976:49–61.
  PubMed
1. Park SN, Park JY, Kook JK. Development of Porphyromonas gingivalis-specific quantitative real-time PCR primers based on the nucleotide sequence of rpoB. J Microbiol 2011;49:315–319.
  PubMed
  
  CrossRef
1. Good PI, Hardin JW. In: Common errors in statistics (and how to avoid them). 3rd ed. Hoboken (NJ): Wiley; 2009.
  CrossRef
1. Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Clin Periodontol 2013;40 Suppl 14:S70–84.
1. Nesse W, Linde A, Abbas F, Spijkervet FK, Dijkstra PU, de Brabander EC, et al. Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol 2009;36:295–300.
  PubMed
  
  CrossRef
1. Iwasaki M, Taylor GW, Nesse W, Vissink A, Yoshihara A, Miyazaki H. Periodontal disease and decreased kidney function in Japanese elderly. Am J Kidney Dis 2012;59:202–209.
  PubMed
  
  CrossRef
1. Radwan-Oczko M, Jaworski A, Duś I, Plonek T, Szulc M, Kustrzycki W. Porphyromonas gingivalis in periodontal pockets and heart valves. Virulence 2014;5:575–580.
  PubMed
  
  CrossRef
1. Belibasakis G, Thurnheer T, Bostanci N. Porphyromonas gingivalis: a heartful oral pathogen? Virulence 2014;5:463–464.
  PubMed
  
  CrossRef
1. Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 2004;28:311–318.
  PubMed
  
  CrossRef
1. Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 2014;66:1090–1100.
  PubMed
  
  CrossRef
1. Hitchon CA, Chandad F, Ferucci ED, Willemze A, Ioan-Facsinay A, van der Woude D, et al. Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 2010;37:1105–1112.
  PubMed
  
  CrossRef
1. Lappin DF, Apatzidou D, Quirke AM, Oliver-Bell J, Butcher JP, Kinane DF, et al. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol 2013;40:907–915.
  PubMed
  
  CrossRef
1. Casarin RC, Del Peloso Ribeiro É, Mariano FS, Nociti FH Jr, Casati MZ, Gonçalves RB. Levels of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, inflammatory cytokines and species-specific immunoglobulin G in generalized aggressive and chronic periodontitis. J Periodontal Res 2010;45:635–642.
  PubMed
  
  CrossRef
1. Mooney J, Adonogianaki E, Riggio MP, Takahashi K, Haerian A, Kinane DF. Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis. Infect Immun 1995;63:3411–3416.
  PubMed
1. Wilton JM, Hurst TJ, Sterne JA. Elevated opsonic activity for Porphyromonas (Bacteroides) gingivalis in serum from patients with a history of destructive periodontal disease. A case: control study. J Clin Periodontol 1993;20:563–569.
  PubMed
  
  CrossRef
1. Fransson C, Berglundh T, Lindhe J. The effect of age on the development of gingivitis. Clinical, microbiological and histological findings. J Clin Periodontol 1996;23:379–385.
  PubMed
  
  CrossRef
1. Kinane DF, Chestnutt IG. Smoking and periodontal disease. Crit Rev Oral Biol Med 2000;11:356–365.
  PubMed
  
  CrossRef
1. Müller HP, Stadermann S, Heinecke A. Longitudinal association between plaque and gingival bleeding in smokers and non-smokers. J Clin Periodontol 2002;29:287–294.
  CrossRef